TAMPA, Fla.--(BUSINESS WIRE)--Neutra Corp. (OTCBB:NTRR) is moving forward with plans to demonstrate how products being delivered by its joint venture with Surface to Air Solutions, Inc. (S2O2) can help eliminate one of the cannabis industry’s most pressing problems: contamination. Just this week, it was reported that the city of Denver ordered hundreds of plants quarantined due to possible exposure to potentially harmful pesticides.
The order affects cannabis crops in Colorado that the state claims were potentially exposed to pesticides not recommended for indoor use or on crops intended for human consumption. It’s the first time that state health authorities have quarantined plants from Colorado’s regulated cannabis market. With the government now stepping in to enforce new rules on pesticides, NTRR and its joint venture partner have developed a plan to help eliminate pesticides from the cannabis industry entirely.
Alongside S2O2, NTRR is working to introduce new products to the U.S. cannabis industry that can help growers eliminate potentially harmful contaminants. A suite of horticultural products being marketed by the joint venture has been carefully engineered to keep plants, surfaces and air inside growing facilities free from microbes, molds, fungus and other adulterants—without the use of pesticides.
Earlier this week, S2O2 inked a letter of intent with DANK Dispensaries and Denver Consulting Group, premiere U.S. cannabis producers, to test and demonstrate the efficacy of its products at the company’s indoor growing operations in Colorado. By verifying these products’ use in eliminating contaminants from cannabis, the joint venture plans to take the first step toward making them industry-standard across the entire regulated sector.
NTRR formed the joint venture with S2O2 last year to market novel and ideal solutions to growers that are concerned about contamination of their crops by microbes, molds, fungus and other pests.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.